ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

No reported Selling, General & Admin figures are available to summarize.

Selling, General & Admin history

Currency unavailable · from the income statement

No Selling, General & Admin data reported for this period type.

Selling, General & Admin vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Selling, General & Admin for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WVEWave Life Sciences Ltd.LTM Mar 2026$79.08M USD+23.9%+14.3%110.1%
STOKStoke Therapeutics, Inc.LTM Mar 2026$71.21M USD+35.2%+19.9%222.0%
PRMEPrime Medicine, Inc.LTM Mar 2026$56.47M USD+8.0%+20.6%1399.8%
MGTXMeiraGTx Holdings plcLTM Mar 2026$52.46M USD-2.3%+4.4%65.8%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$43.57M USD-11.6%+0.0%96.1%
RNAAtrium Therapeutics, Inc.FY2025$41.68M USD——223.8%
BNTCBenitec Biopharma Inc.LTM Mar 2026$34.74M USD+87.8%+52.2%—
SLNSilence Therapeutics plcLTM Mar 2026$23.59M USD—+2.2%2560.2%
PRQRProQR Therapeutics N.V.LTM Mar 2026€14.33M EUR+6.6%-8.9%106.6%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+8.0%+9.3%166.1%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.